Skip to main content

Together we are beating cancer

Donate now

Immune system

Showing 12 out of 116 results
  • Science & Technology
  • Health & Medicine

Building tumours in the lab – a how to guide

Our scientists in London are taking apart tumours and rebuilding artificial versions in the lab to help test the latest treatments. Our scientists in London are taking apart tumours and rebuilding artificial versions in the lab to help test the latest treatments.

by Nick Peel | Analysis | 4 July 2016

4 July 2016

From immunotherapy to targeted cancer treatment, here's our round up of the big news from the annual ASCO conference. From immunotherapy to targeted cancer treatment, here's our round up of the big news from the annual ASCO conference.

by Nick Peel | Analysis | 15 June 2016

15 June 2016

  • Health & Medicine
  • Science & Technology

Science Snaps: switching T cells on – size matters

After 15 years of painstaking work, a team of scientists have revealed the detailed structure of one of the molecules controlling a T cell’s fate. After 15 years of painstaking work, a team of scientists have revealed the detailed structure of one of the molecules controlling a T cell’s fate.

by Emma Smith | Analysis | 3 June 2016

3 June 2016

This entry is part 15 of 30 in the series Science Snaps
%postcontent%

We look back on the key topics and trends discussed at the American Association of Cancer Research's recent Annual Meeting in New Orleans We look back on the key topics and trends discussed at the American Association of Cancer Research's recent Annual Meeting in New Orleans

by Henry Scowcroft | Analysis | 6 May 2016

6 May 2016

T cell

We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells. We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells.

by Alan Worsley | Analysis | 15 April 2016

15 April 2016

Human T cell.

Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system. Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system.

by In collaboration with PA Media Group | News | 11 March 2016

11 March 2016

We take a look at our latest immunotherapy clinical trial, testing a new drug for people with head and neck cancers. We take a look at our latest immunotherapy clinical trial, testing a new drug for people with head and neck cancers.

by Emma Smith | Analysis | 24 February 2016

24 February 2016